Rottinghaus Scott T. 4
4 · ENANTA PHARMACEUTICALS INC · Filed Feb 14, 2025
Insider Transaction Report
Form 4
Rottinghaus Scott T.
Chief Medical Officer
Transactions
- Award
Common Stock
2025-02-12+9,750→ 27,668 total - Tax Payment
Common Stock
2025-02-12$5.59/sh−2,861$15,993→ 24,807 total
Footnotes (2)
- [F1]Represents shares of Enanta common stock issued under performance share units ("PSUs") that vested as a result of performance against two-year research and development milestones in the calendar 2023-2024 period as determined by the Compensation Committee of Enanta's Board of Directors, and then settled with the issuance of the shares of Enanta common stock on February 12, 2025.
- [F2]Represents the number of shares of common stock automatically forfeited by the reporting person pursuant to the terms of the awards to cover withholding taxes due as a result of the settlement of the PSU awards.